IL-17 is involved in the pathogenesis of DN as a pro-inflammatory response in diseases related to obesity and a mediator of autoimmunity and insulin resistance [30]. The gene discussed is IL17A; the disease is obesity due to melanocortin 4 receptor deficiency.